2
Jun 2026
Microenvironmental CTHRC1 protein promotes colorectal cancer tumor growth
A new research paper was published in Volume 17 of Oncotarget on May 20, 2026, titled "Microenvironmental CTHRC1 has a pro-tumorigenic role in colorectal cancer."
Stay Informed!
2
Jun 2026
Novel theranostic approach targets aggressive neuroendocrine prostate cancer
A novel theranostic approach that targets RET -- a newly identified biomarker for neuroendocrine prostate cancer enables high-contrast PET imaging and effective, safe treatment for this highly aggressive malignancy.
2
Jun 2026
Allen Institute launches global research initiative to accelerate new treatments for brain disorders
The Allen Institute, together with partner organizations, today launched the Brain Health accelerator: an ambitious global research initiative seeking to identify the specific brain cells and circuits affected in neurodegenerative disease and other brain disorders and use that knowledge to accelerate the development of new treatments.
2
Jun 2026
Falling fentanyl deaths drive historic drop in American drug overdoses
Researchers from the University of California San Diego have found that U.S. overdose death rates declined dramatically between 2023 and 2024, marking the first recorded drop in all four waves of the nation's overdose crisis.
2
Jun 2026
Cross-reactive T cells target measles and dangerous Nipah viruses
T cells are some of the immune system's most important warriors. They can stop tumor growth and even fight off severe infections.
2
Jun 2026
Cannabis and tobacco co-use lowers cognitive performance in at-risk youth
New research shows that among people at clinical high risk for psychosis, cannabis and tobacco co-use was associated with lower cognitive performance compared to healthy controls.
2
Jun 2026
GLP-1 medications linked to lower breast cancer risk in women
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30 percent less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penn's Abramson Cancer Center.
2
Jun 2026
New discovery provides insights into how seasonal influenza viruses infect people
Scientists investigating how influenza viruses replicate within cells "accidentally" discovered that different flu viruses use distinct strategies to infiltrate cells in the first place.
2
Jun 2026
Stem cell transplantation is the most cost-effective sickle cell treatment
Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new research published in Blood.
2
Jun 2026
Heart failure therapy referrals vary widely across the United Kingdom
Substantial variations in referrals for advanced heart failure therapies are apparent across the UK and Ireland, with no obvious link to geographical location or social deprivation to explain the findings, reveals the first national audit of its kind, published online in the open access journal Open Heart.
